Menopausal Impact of Opportunistic Salpingectomy for Ovarian Cancer Prevention

NCT07423143 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2100

Last updated 2026-02-20

No results posted yet for this study

Summary

The goal of this clinical trial is to find out whether removing the fallopian tubes at the time of hysterectomy leads to an earlier menopause. The study includes women under 55 years of age who previously underwent hysterectomy as participants in the HOPPSA trial, where they were randomly assigned to either removal of the fallopian tubes or no removal.

The main question is:

• Does removing the fallopian tubes at the time of hysterectomy lead to an earlier menopause? Researchers will compare women who had their fallopian tubes removed during hysterectomy with women who had hysterectomy alone to see whether menopause occurs earlier after tube removal. Age at menopause will be estimated by measuring follicle-stimulating hormone (FSH) in small blood samples collected on a paper card.

Participants will:

* Collect 4-5 drops of blood using a finger prick
* Place the drops on a paper card and mail it to the researchers
* Complete an online questionnaire These steps will be done twice, one year apart.

Conditions

Interventions

PROCEDURE

Opportunistic salpingectomy

Removal of the fallopian tubes at the time of hysterectomy

Sponsors & Collaborators

  • Uppsala University

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Örebro University, Sweden

    collaborator OTHER
  • Queen Mary University of London

    collaborator OTHER
  • Region Västerbotten

    collaborator OTHER_GOV
  • Göteborg University

    collaborator OTHER
  • Umeå University

    lead OTHER

Principal Investigators

  • Annika Idahl, MD, PhD, Professor · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2029-02-28
Completion
2057-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07423143 on ClinicalTrials.gov